A
Amy Baldwin
Researcher at Harvard University
Publications - 4
Citations - 126
Amy Baldwin is an academic researcher from Harvard University. The author has contributed to research in topics: Kinase & Cancer cell. The author has an hindex of 3, co-authored 4 publications receiving 118 citations. Previous affiliations of Amy Baldwin include St. George's University & Tufts University.
Papers
More filters
Journal ArticleDOI
Viral Perturbations of Host Networks Reflect Disease Etiology
Natali Gulbahce,Han Yan,Amélie Dricot,Megha Padi,Danielle Byrdsong,Rachel Franchi,Deok-Sun Lee,Deok-Sun Lee,Orit Rozenblatt-Rosen,Jessica C. Mar,Michael A. Calderwood,Amy Baldwin,Amy Baldwin,Bo Zhao,Balaji Santhanam,Pascal Braun,Nicolas Simonis,Nicolas Simonis,Kyung-Won Huh,Kyung-Won Huh,Karin Hellner,Miranda Grace,Alyce A. Chen,Renee Rubio,Jarrod A. Marto,Nicholas A. Christakis,Elliott Kieff,Frederick P. Roth,Jennifer Roecklein-Canfield,Jennifer Roecklein-Canfield,James A. DeCaprio,Michael E. Cusick,John Quackenbush,David E. Hill,Karl Münger,Marc Vidal,Albert-László Barabási,Albert-László Barabási +37 more
TL;DR: In this article, the authors examined whether viral perturbations of host interactome may underlie such virally implicated disease relationships, using as models two different human viruses, Epstein-Barr virus (EBV) and human papillomavirus (HPV).
Patent
Compositions and method for inhibiting tumor growth
Amy Baldwin,Dorre A. Grueneberg,Ed Harlow,Jun Xian,Karl Münger,Karin Hellner,Marcie A. Glicksman,Ross L. Stein,Gregory D. Cuny +8 more
TL;DR: In this article, the authors provide methods and compositions for inhibiting p53 -inactivated cancers, which are preferentially inhibited compared to normal cells by inhibiting tumor survival kinases that are required for growth of tumor cells but not normal cells.
Journal ArticleDOI
Intrinsic fluorescence changes associated with apoptosis of human epithelial keratinocytes.
Patent
Compositions and Methods for Inhibiting Tumor Growth
Amy Baldwin,Dorre A. Grueneberg,Ed Harlow,Jun Xian,Karl Münger,Karin Hellner,Marcie A. Glicksman,Ross L. Stein,Gregory D. Cuny +8 more
TL;DR: In this paper, the authors provide methods and compositions for inhibiting p53-inactivated cancers by inhibiting tumor survival kinases that are required for growth of tumor cells but not normal cells.